1217310-65-0 Usage
General Description
Quetiapine-d4 HeMifuMarate is a deuterated form of quetiapine, which is a medication used to treat schizophrenia, bipolar disorder, and major depressive disorder. It works by affecting the balance of neurotransmitters in the brain, specifically by blocking the dopamine and serotonin receptors. The deuterated form of quetiapine has been labeled with deuterium atoms, which can be used in pharmacokinetic and pharmacodynamic studies to better understand the drug's metabolism and efficacy. The HeMifuMarate form of the medication is a salt form, which can affect the drug's solubility, stability, and pharmacokinetic properties. Overall, the combination of quetiapine-d4 and HeMifuMarate provides a more detailed understanding of the drug's actions in the body and its potential for use in research and clinical practice.
Check Digit Verification of cas no
The CAS Registry Mumber 1217310-65-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,7,3,1 and 0 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1217310-65:
(9*1)+(8*2)+(7*1)+(6*7)+(5*3)+(4*1)+(3*0)+(2*6)+(1*5)=110
110 % 10 = 0
So 1217310-65-0 is a valid CAS Registry Number.
1217310-65-0Relevant articles and documents
DIBENZOTHIAZEPINE MODULATORS OF DOPAMINE, ALPHA ADRENERGIC, AND SEROTONIN RECEPTORS
-
Page/Page column 32, (2010/04/23)
The present invention relates to new dibenzothiazepine modulators of D1 receptors, D2 receptors, alpha-1 adrenergic receptors, alpha-2 adrenergic receptors, H1 receptors, 5-HT1A receptors, and/or 5-HT2 receptors, pharmaceutical compositions thereof, and methods of use thereof.
